Metformin – an old drug with a new face

Danuta Galicka-Latała; Maciej T. Małecki

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

4/2007
vol. 10

Send email

Copy url:

abstract:

Metformin – an old drug with a new face

Danuta Galicka-Latała

,

Maciej T. Małecki

Przew Lek 2007; 4: 31-42

Online publish date: 2007/07/09

View full text Get citation

One of the most difficult current medical problems is the growing epidemic of type 2 diabetes mellitus. This disease results in dangerous chronic complications and increased mortality, mainly due to cardiovascular causes. Two major pathophysiological mechanisms underlying the occurrence of type 2 diabetes are impaired insulin secretion and decreased insulin sensitivity. Metformin is the most popular drug enhancing sensitivity to insulin. Over the last decade it has been the subject of scientific and clinical studies that clarified its role in the field of diabetology. This review summarizes the role of metformin in type 2 diabetes therapy.

keywords:

Metformin – an old drug with a new face

Danuta Galicka-Latała , Maciej T. Małecki

type 2 diabetes mellitus, insulin sensitivity, metformin

Danuta Galicka-Latała

,

Maciej T. Małecki